HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Reglodi Selected Research

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)

7/2019Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
12/2018PACAP deficiency as a model of aging.
1/2018Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents.
1/2018Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.
10/2017Effects of pituitary adenylate cyclase activating polypeptide on small intestinal INT 407 cells.
10/2016The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
4/2016Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
9/2015Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice.
11/2014Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.
11/2014Structural and morphometric comparison of the molar teeth in pre-eruptive developmental stage of PACAP-deficient and wild-type mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Reglodi Research Topics

Disease

9Wounds and Injuries (Trauma)
01/2018 - 07/2010
9Ischemia
10/2016 - 01/2000
8Retinal Degeneration
07/2019 - 09/2007
6Infarction (Infarctions)
01/2012 - 01/2000
5Hypoxia (Hypoxemia)
10/2017 - 04/2009
5Brain Ischemia (Cerebral Ischemia)
11/2012 - 12/2002
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 07/2010
3Parkinson Disease (Parkinson's Disease)
01/2018 - 01/2011
3Ganglion Cysts (Ganglion)
04/2016 - 09/2007
3Diabetic Retinopathy (Retinopathy, Diabetic)
04/2016 - 07/2010
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2002 - 01/2000
2Inflammation (Inflammations)
12/2018 - 11/2012
2Edema (Dropsy)
10/2014 - 09/2007
2Neurogenic Inflammation
10/2014 - 09/2007
2Reperfusion Injury
11/2012 - 07/2010
2Optic Nerve Injuries
11/2012 - 07/2010
2Choriocarcinoma
11/2010 - 04/2009
1Premature Aging
12/2018
1Amyloidosis
12/2018
1Sudden Infant Death (SID)
11/2014
1Ototoxicity
01/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
04/2013
1Heart Diseases (Heart Disease)
11/2012
1Encephalomyelitis (Myeloencephalitis)
11/2012
1Cardiomyopathies (Cardiomyopathy)
11/2012
1Neoplasms (Cancer)
11/2012
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2012
1Allergic Contact Dermatitis
11/2012
1Carcinogenesis
11/2012
1Mood Disorders (Mood Disorder)
01/2012
1Huntington Disease (Huntington's Disease)
01/2011
1Alzheimer Disease (Alzheimer's Disease)
01/2011
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2011
1Hyperalgesia
10/2010
1Pain (Aches)
10/2010
1Retinal Diseases
07/2010
1Spinal Cord Injuries (Spinal Cord Injury)
07/2010
1Starvation
06/2007
1Hypothermia
01/2007
1Stroke (Strokes)
06/2000
1Hyperthermia
01/2000

Drug/Important Bio-Agent (IBA)

32Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
07/2019 - 01/2000
4Retinaldehyde (Retinal)IBA
12/2018 - 01/2012
4CytokinesIBA
10/2016 - 11/2012
4Peptides (Polypeptides)IBA
04/2016 - 07/2010
3Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
07/2019 - 10/2014
3Neuroprotective AgentsIBA
02/2003 - 01/2000
2insect maxadilan proteinIBA
10/2016 - 10/2014
2Sodium Glutamate (Accent)IBA
03/2014 - 09/2007
2Streptozocin (Streptozotocin)FDA Link
04/2013 - 07/2010
2NeuropeptidesIBA
11/2012 - 07/2010
2resiniferatoxinIBA
10/2010 - 09/2007
2Glutamic Acid (Glutamate)FDA Link
07/2010 - 09/2007
1Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2018
1EnzymesIBA
09/2015
1Superoxide DismutaseIBA
09/2015
1AnkyrinsIBA
10/2014
1Evans Blue (Blue, Evans)FDA Link
10/2014
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2014
1UrocortinsIBA
03/2014
1KanamycinFDA Link
01/2014
1Calcium-Binding ProteinsIBA
01/2014
1Carrier Proteins (Binding Protein)IBA
01/2014
1EndotoxinsIBA
11/2012
1OxazoloneIBA
11/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2012
1Methotrexate (Mexate)FDA LinkGeneric
11/2010
1AnisomycinIBA
07/2010
1cobaltous chloride (cobalt(II)chloride)IBA
07/2010
1ThapsigarginIBA
07/2010
1Kainic Acid (Kainate)IBA
07/2010
1Capsaicin (Zostrix)FDA Link
09/2007
1CarrageenanIBA
09/2007
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2007
1CaspasesIBA
01/2007
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2007
1triphenyltetrazoliumIBA
06/2000

Therapy/Procedure

1Lasers (Laser)
10/2014
1Ligation
10/2010
1Injections
12/2002